Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen's Letter to the Editor re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates

Eur Urol. 2022 Sep;82(3):e68-e69. doi: 10.1016/j.eururo.2022.05.014. Epub 2022 Jun 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abiraterone Acetate
  • Humans
  • Male
  • Outcome Assessment, Health Care
  • Prostatic Neoplasms*
  • Prostatic Neoplasms, Castration-Resistant*

Substances

  • Abiraterone Acetate